Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Furnari

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nature|June 26, 2010
Gene-expression forum: Decoy for microRNAsIsidore Rigoutsos, Frank Furnari
Molecular Cell|April 6, 2005
PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growthTianyan Gao, Frank Furnari, Alexandra C Newton
Neuro-Oncology|January 13, 2016
Epidermal growth factor receptor targeting and challenges in glioblastomaAmy Haseley Thorne, Ciro Zanca, Frank Furnari
Cell Cycle (Georgetown, Tex.)|April 21, 2010
Escape from targeted inhibition: the dark side of kinase inhibitor therapyJill Wykosky, Akitake Mukasa, Frank Furnari, et al.
Chinese Journal of Cancer|January 4, 2011
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitationsJill Wykosky, Tim Fenton, Frank Furnari, et al.
Brain Tumor Pathology|February 11, 2005
Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastomaRyo Nishikawa, Tatsuya Sugiyama, Yoshitaka Narita, et al.
Current Biology : CB|June 9, 2004
Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencingJagesh V Shah, Elliot Botvinick, Zahid Bonday, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependenceAkitake Mukasa, Jill Wykosky, Keith L Ligon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2011
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cellsJingjing Hu, Minji Jo, Webster K Cavenee, et al.
The Journal of Experimental Medicine|December 14, 2011
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastomaMing Li, Akitake Mukasa, Maria del-Mar Inda, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nature|June 26, 2010
Gene-expression forum: Decoy for microRNAsIsidore Rigoutsos, Frank Furnari
Molecular Cell|April 6, 2005
PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growthTianyan Gao, Frank Furnari, Alexandra C Newton
Neuro-Oncology|January 13, 2016
Epidermal growth factor receptor targeting and challenges in glioblastomaAmy Haseley Thorne, Ciro Zanca, Frank Furnari
Cell Cycle (Georgetown, Tex.)|April 21, 2010
Escape from targeted inhibition: the dark side of kinase inhibitor therapyJill Wykosky, Akitake Mukasa, Frank Furnari, et al.
Chinese Journal of Cancer|January 4, 2011
Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitationsJill Wykosky, Tim Fenton, Frank Furnari, et al.
Brain Tumor Pathology|February 11, 2005
Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastomaRyo Nishikawa, Tatsuya Sugiyama, Yoshitaka Narita, et al.
Current Biology : CB|June 9, 2004
Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencingJagesh V Shah, Elliot Botvinick, Zahid Bonday, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependenceAkitake Mukasa, Jill Wykosky, Keith L Ligon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2011
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cellsJingjing Hu, Minji Jo, Webster K Cavenee, et al.
The Journal of Experimental Medicine|December 14, 2011
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastomaMing Li, Akitake Mukasa, Maria del-Mar Inda, et al.
Pageof 4